The global Pandemic Influenza Vaccine market size was valued at USD 8056.5 million in 2022 and is forecast to a readjusted size of USD 11570 million by 2029 with a CAGR of 5.3% during review period.
Report includes an overview of the development of the Pandemic Influenza Vaccine industry chain, the market status of 6 Months to 3 Years (Trivalent Influenza Vaccine, Quadrivalent Influenza Vaccine), > 3 Years (Trivalent Influenza Vaccine, Quadrivalent Influenza Vaccine), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of Pandemic Influenza Vaccine.
Global key players of Pandemic Influenza Vaccine include Sanofi, CSL and GSK, etc. The top five players hold a share about 75%. North America is the largest market, has a share about 50%.
Regionally, the report analyzes the Pandemic Influenza Vaccine markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global Pandemic Influenza Vaccine market, with robust domestic demand, supportive policies, and a strong manufacturing base.
Key Features:
The report presents comprehensive understanding of the Pandemic Influenza Vaccine market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the Pandemic Influenza Vaccine industry.
The report involves analyzing the market at a macro level:
Market Sizing and Segmentation: Report collect data on the overall market size, including the sales quantity (M Units), revenue generated, and market share of different by Type (e.g., Trivalent Influenza Vaccine, Quadrivalent Influenza Vaccine).
Industry Analysis: Report analyse the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the Pandemic Influenza Vaccine market.
Regional Analysis: The report involves examining the Pandemic Influenza Vaccine market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets.
Market Projections: Report covers the gathered data and analysis to make future projections and forecasts for the Pandemic Influenza Vaccine market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.
The report also involves a more granular approach to Pandemic Influenza Vaccine:
Company Analysis: Report covers individual Pandemic Influenza Vaccine manufacturers, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.
Consumer Analysis: Report covers data on consumer behavior, preferences, and attitudes towards Pandemic Influenza Vaccine This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Application (6 Months to 3 Years, > 3 Years).
Technology Analysis: Report covers specific technologies relevant to Pandemic Influenza Vaccine. It assesses the current state, advancements, and potential future developments in Pandemic Influenza Vaccine areas.
Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the Pandemic Influenza Vaccine market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.
Market Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.
Sanofi
CSL
GSK
Viatris
AstraZeneca
Hualan Bio
Changchun Institute of Biological
Sinovac
BCHT
Jiangsu GDK
KM Biologics
Trivalent Influenza Vaccine
Quadrivalent Influenza Vaccine
6 Months to 3 Years
> 3 Years
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
Chapter 1, to describe Pandemic Influenza Vaccine product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Pandemic Influenza Vaccine, with price, sales, revenue and global market share of Pandemic Influenza Vaccine from 2018 to 2023.
Chapter 3, the Pandemic Influenza Vaccine competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Pandemic Influenza Vaccine breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2018 to 2029.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2018 to 2029.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2022.and Pandemic Influenza Vaccine market forecast, by regions, type and application, with sales and revenue, from 2024 to 2029.
Chapter 12, market dynamics, drivers, restraints, trends and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Pandemic Influenza Vaccine.
Chapter 14 and 15, to describe Pandemic Influenza Vaccine sales channel, distributors, customers, research findings and conclusion.
1 Market Overview
1.1 Product Overview and Scope of Pandemic Influenza Vaccine
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global Pandemic Influenza Vaccine Consumption Value by Type: 2018 Versus 2022 Versus 2029
1.3.2 Trivalent Influenza Vaccine
1.3.3 Quadrivalent Influenza Vaccine
1.4 Market Analysis by Application
1.4.1 Overview: Global Pandemic Influenza Vaccine Consumption Value by Application: 2018 Versus 2022 Versus 2029
1.4.2 6 Months to 3 Years
1.4.3 > 3 Years
1.5 Global Pandemic Influenza Vaccine Market Size & Forecast
1.5.1 Global Pandemic Influenza Vaccine Consumption Value (2018 & 2022 & 2029)
1.5.2 Global Pandemic Influenza Vaccine Sales Quantity (2018-2029)
1.5.3 Global Pandemic Influenza Vaccine Average Price (2018-2029)
2 Manufacturers Profiles
2.1 Sanofi
2.1.1 Sanofi Details
2.1.2 Sanofi Major Business
2.1.3 Sanofi Pandemic Influenza Vaccine Product and Services
2.1.4 Sanofi Pandemic Influenza Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.1.5 Sanofi Recent Developments/Updates
2.2 CSL
2.2.1 CSL Details
2.2.2 CSL Major Business
2.2.3 CSL Pandemic Influenza Vaccine Product and Services
2.2.4 CSL Pandemic Influenza Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.2.5 CSL Recent Developments/Updates
2.3 GSK
2.3.1 GSK Details
2.3.2 GSK Major Business
2.3.3 GSK Pandemic Influenza Vaccine Product and Services
2.3.4 GSK Pandemic Influenza Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.3.5 GSK Recent Developments/Updates
2.4 Viatris
2.4.1 Viatris Details
2.4.2 Viatris Major Business
2.4.3 Viatris Pandemic Influenza Vaccine Product and Services
2.4.4 Viatris Pandemic Influenza Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.4.5 Viatris Recent Developments/Updates
2.5 AstraZeneca
2.5.1 AstraZeneca Details
2.5.2 AstraZeneca Major Business
2.5.3 AstraZeneca Pandemic Influenza Vaccine Product and Services
2.5.4 AstraZeneca Pandemic Influenza Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.5.5 AstraZeneca Recent Developments/Updates
2.6 Hualan Bio
2.6.1 Hualan Bio Details
2.6.2 Hualan Bio Major Business
2.6.3 Hualan Bio Pandemic Influenza Vaccine Product and Services
2.6.4 Hualan Bio Pandemic Influenza Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.6.5 Hualan Bio Recent Developments/Updates
2.7 Changchun Institute of Biological
2.7.1 Changchun Institute of Biological Details
2.7.2 Changchun Institute of Biological Major Business
2.7.3 Changchun Institute of Biological Pandemic Influenza Vaccine Product and Services
2.7.4 Changchun Institute of Biological Pandemic Influenza Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.7.5 Changchun Institute of Biological Recent Developments/Updates
2.8 Sinovac
2.8.1 Sinovac Details
2.8.2 Sinovac Major Business
2.8.3 Sinovac Pandemic Influenza Vaccine Product and Services
2.8.4 Sinovac Pandemic Influenza Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.8.5 Sinovac Recent Developments/Updates
2.9 BCHT
2.9.1 BCHT Details
2.9.2 BCHT Major Business
2.9.3 BCHT Pandemic Influenza Vaccine Product and Services
2.9.4 BCHT Pandemic Influenza Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.9.5 BCHT Recent Developments/Updates
2.10 Jiangsu GDK
2.10.1 Jiangsu GDK Details
2.10.2 Jiangsu GDK Major Business
2.10.3 Jiangsu GDK Pandemic Influenza Vaccine Product and Services
2.10.4 Jiangsu GDK Pandemic Influenza Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.10.5 Jiangsu GDK Recent Developments/Updates
2.11 KM Biologics
2.11.1 KM Biologics Details
2.11.2 KM Biologics Major Business
2.11.3 KM Biologics Pandemic Influenza Vaccine Product and Services
2.11.4 KM Biologics Pandemic Influenza Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.11.5 KM Biologics Recent Developments/Updates
3 Competitive Environment: Pandemic Influenza Vaccine by Manufacturer
3.1 Global Pandemic Influenza Vaccine Sales Quantity by Manufacturer (2018-2023)
3.2 Global Pandemic Influenza Vaccine Revenue by Manufacturer (2018-2023)
3.3 Global Pandemic Influenza Vaccine Average Price by Manufacturer (2018-2023)
3.4 Market Share Analysis (2022)
3.4.1 Producer Shipments of Pandemic Influenza Vaccine by Manufacturer Revenue ($MM) and Market Share (%): 2022
3.4.2 Top 3 Pandemic Influenza Vaccine Manufacturer Market Share in 2022
3.4.2 Top 6 Pandemic Influenza Vaccine Manufacturer Market Share in 2022
3.5 Pandemic Influenza Vaccine Market: Overall Company Footprint Analysis
3.5.1 Pandemic Influenza Vaccine Market: Region Footprint
3.5.2 Pandemic Influenza Vaccine Market: Company Product Type Footprint
3.5.3 Pandemic Influenza Vaccine Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4 Consumption Analysis by Region
4.1 Global Pandemic Influenza Vaccine Market Size by Region
4.1.1 Global Pandemic Influenza Vaccine Sales Quantity by Region (2018-2029)
4.1.2 Global Pandemic Influenza Vaccine Consumption Value by Region (2018-2029)
4.1.3 Global Pandemic Influenza Vaccine Average Price by Region (2018-2029)
4.2 North America Pandemic Influenza Vaccine Consumption Value (2018-2029)
4.3 Europe Pandemic Influenza Vaccine Consumption Value (2018-2029)
4.4 Asia-Pacific Pandemic Influenza Vaccine Consumption Value (2018-2029)
4.5 South America Pandemic Influenza Vaccine Consumption Value (2018-2029)
4.6 Middle East and Africa Pandemic Influenza Vaccine Consumption Value (2018-2029)
5 Market Segment by Type
5.1 Global Pandemic Influenza Vaccine Sales Quantity by Type (2018-2029)
5.2 Global Pandemic Influenza Vaccine Consumption Value by Type (2018-2029)
5.3 Global Pandemic Influenza Vaccine Average Price by Type (2018-2029)
6 Market Segment by Application
6.1 Global Pandemic Influenza Vaccine Sales Quantity by Application (2018-2029)
6.2 Global Pandemic Influenza Vaccine Consumption Value by Application (2018-2029)
6.3 Global Pandemic Influenza Vaccine Average Price by Application (2018-2029)
7 North America
7.1 North America Pandemic Influenza Vaccine Sales Quantity by Type (2018-2029)
7.2 North America Pandemic Influenza Vaccine Sales Quantity by Application (2018-2029)
7.3 North America Pandemic Influenza Vaccine Market Size by Country
7.3.1 North America Pandemic Influenza Vaccine Sales Quantity by Country (2018-2029)
7.3.2 North America Pandemic Influenza Vaccine Consumption Value by Country (2018-2029)
7.3.3 United States Market Size and Forecast (2018-2029)
7.3.4 Canada Market Size and Forecast (2018-2029)
7.3.5 Mexico Market Size and Forecast (2018-2029)
8 Europe
8.1 Europe Pandemic Influenza Vaccine Sales Quantity by Type (2018-2029)
8.2 Europe Pandemic Influenza Vaccine Sales Quantity by Application (2018-2029)
8.3 Europe Pandemic Influenza Vaccine Market Size by Country
8.3.1 Europe Pandemic Influenza Vaccine Sales Quantity by Country (2018-2029)
8.3.2 Europe Pandemic Influenza Vaccine Consumption Value by Country (2018-2029)
8.3.3 Germany Market Size and Forecast (2018-2029)
8.3.4 France Market Size and Forecast (2018-2029)
8.3.5 United Kingdom Market Size and Forecast (2018-2029)
8.3.6 Russia Market Size and Forecast (2018-2029)
8.3.7 Italy Market Size and Forecast (2018-2029)
9 Asia-Pacific
9.1 Asia-Pacific Pandemic Influenza Vaccine Sales Quantity by Type (2018-2029)
9.2 Asia-Pacific Pandemic Influenza Vaccine Sales Quantity by Application (2018-2029)
9.3 Asia-Pacific Pandemic Influenza Vaccine Market Size by Region
9.3.1 Asia-Pacific Pandemic Influenza Vaccine Sales Quantity by Region (2018-2029)
9.3.2 Asia-Pacific Pandemic Influenza Vaccine Consumption Value by Region (2018-2029)
9.3.3 China Market Size and Forecast (2018-2029)
9.3.4 Japan Market Size and Forecast (2018-2029)
9.3.5 Korea Market Size and Forecast (2018-2029)
9.3.6 India Market Size and Forecast (2018-2029)
9.3.7 Southeast Asia Market Size and Forecast (2018-2029)
9.3.8 Australia Market Size and Forecast (2018-2029)
10 South America
10.1 South America Pandemic Influenza Vaccine Sales Quantity by Type (2018-2029)
10.2 South America Pandemic Influenza Vaccine Sales Quantity by Application (2018-2029)
10.3 South America Pandemic Influenza Vaccine Market Size by Country
10.3.1 South America Pandemic Influenza Vaccine Sales Quantity by Country (2018-2029)
10.3.2 South America Pandemic Influenza Vaccine Consumption Value by Country (2018-2029)
10.3.3 Brazil Market Size and Forecast (2018-2029)
10.3.4 Argentina Market Size and Forecast (2018-2029)
11 Middle East & Africa
11.1 Middle East & Africa Pandemic Influenza Vaccine Sales Quantity by Type (2018-2029)
11.2 Middle East & Africa Pandemic Influenza Vaccine Sales Quantity by Application (2018-2029)
11.3 Middle East & Africa Pandemic Influenza Vaccine Market Size by Country
11.3.1 Middle East & Africa Pandemic Influenza Vaccine Sales Quantity by Country (2018-2029)
11.3.2 Middle East & Africa Pandemic Influenza Vaccine Consumption Value by Country (2018-2029)
11.3.3 Turkey Market Size and Forecast (2018-2029)
11.3.4 Egypt Market Size and Forecast (2018-2029)
11.3.5 Saudi Arabia Market Size and Forecast (2018-2029)
11.3.6 South Africa Market Size and Forecast (2018-2029)
12 Market Dynamics
12.1 Pandemic Influenza Vaccine Market Drivers
12.2 Pandemic Influenza Vaccine Market Restraints
12.3 Pandemic Influenza Vaccine Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
13 Raw Material and Industry Chain
13.1 Raw Material of Pandemic Influenza Vaccine and Key Manufacturers
13.2 Manufacturing Costs Percentage of Pandemic Influenza Vaccine
13.3 Pandemic Influenza Vaccine Production Process
13.4 Pandemic Influenza Vaccine Industrial Chain
14 Shipments by Distribution Channel
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 Pandemic Influenza Vaccine Typical Distributors
14.3 Pandemic Influenza Vaccine Typical Customers
15 Research Findings and Conclusion
16 Appendix
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer
List of Tables
Table 1. Global Pandemic Influenza Vaccine Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Table 2. Global Pandemic Influenza Vaccine Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Table 3. Sanofi Basic Information, Manufacturing Base and Competitors
Table 4. Sanofi Major Business
Table 5. Sanofi Pandemic Influenza Vaccine Product and Services
Table 6. Sanofi Pandemic Influenza Vaccine Sales Quantity (M Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 7. Sanofi Recent Developments/Updates
Table 8. CSL Basic Information, Manufacturing Base and Competitors
Table 9. CSL Major Business
Table 10. CSL Pandemic Influenza Vaccine Product and Services
Table 11. CSL Pandemic Influenza Vaccine Sales Quantity (M Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 12. CSL Recent Developments/Updates
Table 13. GSK Basic Information, Manufacturing Base and Competitors
Table 14. GSK Major Business
Table 15. GSK Pandemic Influenza Vaccine Product and Services
Table 16. GSK Pandemic Influenza Vaccine Sales Quantity (M Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 17. GSK Recent Developments/Updates
Table 18. Viatris Basic Information, Manufacturing Base and Competitors
Table 19. Viatris Major Business
Table 20. Viatris Pandemic Influenza Vaccine Product and Services
Table 21. Viatris Pandemic Influenza Vaccine Sales Quantity (M Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 22. Viatris Recent Developments/Updates
Table 23. AstraZeneca Basic Information, Manufacturing Base and Competitors
Table 24. AstraZeneca Major Business
Table 25. AstraZeneca Pandemic Influenza Vaccine Product and Services
Table 26. AstraZeneca Pandemic Influenza Vaccine Sales Quantity (M Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 27. AstraZeneca Recent Developments/Updates
Table 28. Hualan Bio Basic Information, Manufacturing Base and Competitors
Table 29. Hualan Bio Major Business
Table 30. Hualan Bio Pandemic Influenza Vaccine Product and Services
Table 31. Hualan Bio Pandemic Influenza Vaccine Sales Quantity (M Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 32. Hualan Bio Recent Developments/Updates
Table 33. Changchun Institute of Biological Basic Information, Manufacturing Base and Competitors
Table 34. Changchun Institute of Biological Major Business
Table 35. Changchun Institute of Biological Pandemic Influenza Vaccine Product and Services
Table 36. Changchun Institute of Biological Pandemic Influenza Vaccine Sales Quantity (M Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 37. Changchun Institute of Biological Recent Developments/Updates
Table 38. Sinovac Basic Information, Manufacturing Base and Competitors
Table 39. Sinovac Major Business
Table 40. Sinovac Pandemic Influenza Vaccine Product and Services
Table 41. Sinovac Pandemic Influenza Vaccine Sales Quantity (M Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 42. Sinovac Recent Developments/Updates
Table 43. BCHT Basic Information, Manufacturing Base and Competitors
Table 44. BCHT Major Business
Table 45. BCHT Pandemic Influenza Vaccine Product and Services
Table 46. BCHT Pandemic Influenza Vaccine Sales Quantity (M Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 47. BCHT Recent Developments/Updates
Table 48. Jiangsu GDK Basic Information, Manufacturing Base and Competitors
Table 49. Jiangsu GDK Major Business
Table 50. Jiangsu GDK Pandemic Influenza Vaccine Product and Services
Table 51. Jiangsu GDK Pandemic Influenza Vaccine Sales Quantity (M Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 52. Jiangsu GDK Recent Developments/Updates
Table 53. KM Biologics Basic Information, Manufacturing Base and Competitors
Table 54. KM Biologics Major Business
Table 55. KM Biologics Pandemic Influenza Vaccine Product and Services
Table 56. KM Biologics Pandemic Influenza Vaccine Sales Quantity (M Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 57. KM Biologics Recent Developments/Updates
Table 58. Global Pandemic Influenza Vaccine Sales Quantity by Manufacturer (2018-2023) & (M Units)
Table 59. Global Pandemic Influenza Vaccine Revenue by Manufacturer (2018-2023) & (USD Million)
Table 60. Global Pandemic Influenza Vaccine Average Price by Manufacturer (2018-2023) & (US$/Unit)
Table 61. Market Position of Manufacturers in Pandemic Influenza Vaccine, (Tier 1, Tier 2, and Tier 3), Based on Consumption Value in 2022
Table 62. Head Office and Pandemic Influenza Vaccine Production Site of Key Manufacturer
Table 63. Pandemic Influenza Vaccine Market: Company Product Type Footprint
Table 64. Pandemic Influenza Vaccine Market: Company Product Application Footprint
Table 65. Pandemic Influenza Vaccine New Market Entrants and Barriers to Market Entry
Table 66. Pandemic Influenza Vaccine Mergers, Acquisition, Agreements, and Collaborations
Table 67. Global Pandemic Influenza Vaccine Sales Quantity by Region (2018-2023) & (M Units)
Table 68. Global Pandemic Influenza Vaccine Sales Quantity by Region (2024-2029) & (M Units)
Table 69. Global Pandemic Influenza Vaccine Consumption Value by Region (2018-2023) & (USD Million)
Table 70. Global Pandemic Influenza Vaccine Consumption Value by Region (2024-2029) & (USD Million)
Table 71. Global Pandemic Influenza Vaccine Average Price by Region (2018-2023) & (US$/Unit)
Table 72. Global Pandemic Influenza Vaccine Average Price by Region (2024-2029) & (US$/Unit)
Table 73. Global Pandemic Influenza Vaccine Sales Quantity by Type (2018-2023) & (M Units)
Table 74. Global Pandemic Influenza Vaccine Sales Quantity by Type (2024-2029) & (M Units)
Table 75. Global Pandemic Influenza Vaccine Consumption Value by Type (2018-2023) & (USD Million)
Table 76. Global Pandemic Influenza Vaccine Consumption Value by Type (2024-2029) & (USD Million)
Table 77. Global Pandemic Influenza Vaccine Average Price by Type (2018-2023) & (US$/Unit)
Table 78. Global Pandemic Influenza Vaccine Average Price by Type (2024-2029) & (US$/Unit)
Table 79. Global Pandemic Influenza Vaccine Sales Quantity by Application (2018-2023) & (M Units)
Table 80. Global Pandemic Influenza Vaccine Sales Quantity by Application (2024-2029) & (M Units)
Table 81. Global Pandemic Influenza Vaccine Consumption Value by Application (2018-2023) & (USD Million)
Table 82. Global Pandemic Influenza Vaccine Consumption Value by Application (2024-2029) & (USD Million)
Table 83. Global Pandemic Influenza Vaccine Average Price by Application (2018-2023) & (US$/Unit)
Table 84. Global Pandemic Influenza Vaccine Average Price by Application (2024-2029) & (US$/Unit)
Table 85. North America Pandemic Influenza Vaccine Sales Quantity by Type (2018-2023) & (M Units)
Table 86. North America Pandemic Influenza Vaccine Sales Quantity by Type (2024-2029) & (M Units)
Table 87. North America Pandemic Influenza Vaccine Sales Quantity by Application (2018-2023) & (M Units)
Table 88. North America Pandemic Influenza Vaccine Sales Quantity by Application (2024-2029) & (M Units)
Table 89. North America Pandemic Influenza Vaccine Sales Quantity by Country (2018-2023) & (M Units)
Table 90. North America Pandemic Influenza Vaccine Sales Quantity by Country (2024-2029) & (M Units)
Table 91. North America Pandemic Influenza Vaccine Consumption Value by Country (2018-2023) & (USD Million)
Table 92. North America Pandemic Influenza Vaccine Consumption Value by Country (2024-2029) & (USD Million)
Table 93. Europe Pandemic Influenza Vaccine Sales Quantity by Type (2018-2023) & (M Units)
Table 94. Europe Pandemic Influenza Vaccine Sales Quantity by Type (2024-2029) & (M Units)
Table 95. Europe Pandemic Influenza Vaccine Sales Quantity by Application (2018-2023) & (M Units)
Table 96. Europe Pandemic Influenza Vaccine Sales Quantity by Application (2024-2029) & (M Units)
Table 97. Europe Pandemic Influenza Vaccine Sales Quantity by Country (2018-2023) & (M Units)
Table 98. Europe Pandemic Influenza Vaccine Sales Quantity by Country (2024-2029) & (M Units)
Table 99. Europe Pandemic Influenza Vaccine Consumption Value by Country (2018-2023) & (USD Million)
Table 100. Europe Pandemic Influenza Vaccine Consumption Value by Country (2024-2029) & (USD Million)
Table 101. Asia-Pacific Pandemic Influenza Vaccine Sales Quantity by Type (2018-2023) & (M Units)
Table 102. Asia-Pacific Pandemic Influenza Vaccine Sales Quantity by Type (2024-2029) & (M Units)
Table 103. Asia-Pacific Pandemic Influenza Vaccine Sales Quantity by Application (2018-2023) & (M Units)
Table 104. Asia-Pacific Pandemic Influenza Vaccine Sales Quantity by Application (2024-2029) & (M Units)
Table 105. Asia-Pacific Pandemic Influenza Vaccine Sales Quantity by Region (2018-2023) & (M Units)
Table 106. Asia-Pacific Pandemic Influenza Vaccine Sales Quantity by Region (2024-2029) & (M Units)
Table 107. Asia-Pacific Pandemic Influenza Vaccine Consumption Value by Region (2018-2023) & (USD Million)
Table 108. Asia-Pacific Pandemic Influenza Vaccine Consumption Value by Region (2024-2029) & (USD Million)
Table 109. South America Pandemic Influenza Vaccine Sales Quantity by Type (2018-2023) & (M Units)
Table 110. South America Pandemic Influenza Vaccine Sales Quantity by Type (2024-2029) & (M Units)
Table 111. South America Pandemic Influenza Vaccine Sales Quantity by Application (2018-2023) & (M Units)
Table 112. South America Pandemic Influenza Vaccine Sales Quantity by Application (2024-2029) & (M Units)
Table 113. South America Pandemic Influenza Vaccine Sales Quantity by Country (2018-2023) & (M Units)
Table 114. South America Pandemic Influenza Vaccine Sales Quantity by Country (2024-2029) & (M Units)
Table 115. South America Pandemic Influenza Vaccine Consumption Value by Country (2018-2023) & (USD Million)
Table 116. South America Pandemic Influenza Vaccine Consumption Value by Country (2024-2029) & (USD Million)
Table 117. Middle East & Africa Pandemic Influenza Vaccine Sales Quantity by Type (2018-2023) & (M Units)
Table 118. Middle East & Africa Pandemic Influenza Vaccine Sales Quantity by Type (2024-2029) & (M Units)
Table 119. Middle East & Africa Pandemic Influenza Vaccine Sales Quantity by Application (2018-2023) & (M Units)
Table 120. Middle East & Africa Pandemic Influenza Vaccine Sales Quantity by Application (2024-2029) & (M Units)
Table 121. Middle East & Africa Pandemic Influenza Vaccine Sales Quantity by Region (2018-2023) & (M Units)
Table 122. Middle East & Africa Pandemic Influenza Vaccine Sales Quantity by Region (2024-2029) & (M Units)
Table 123. Middle East & Africa Pandemic Influenza Vaccine Consumption Value by Region (2018-2023) & (USD Million)
Table 124. Middle East & Africa Pandemic Influenza Vaccine Consumption Value by Region (2024-2029) & (USD Million)
Table 125. Pandemic Influenza Vaccine Raw Material
Table 126. Key Manufacturers of Pandemic Influenza Vaccine Raw Materials
Table 127. Pandemic Influenza Vaccine Typical Distributors
Table 128. Pandemic Influenza Vaccine Typical Customers
List of Figures
Figure 1. Pandemic Influenza Vaccine Picture
Figure 2. Global Pandemic Influenza Vaccine Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 3. Global Pandemic Influenza Vaccine Consumption Value Market Share by Type in 2022
Figure 4. Trivalent Influenza Vaccine Examples
Figure 5. Quadrivalent Influenza Vaccine Examples
Figure 6. Global Pandemic Influenza Vaccine Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Figure 7. Global Pandemic Influenza Vaccine Consumption Value Market Share by Application in 2022
Figure 8. 6 Months to 3 Years Examples
Figure 9. > 3 Years Examples
Figure 10. Global Pandemic Influenza Vaccine Consumption Value, (USD Million): 2018 & 2022 & 2029
Figure 11. Global Pandemic Influenza Vaccine Consumption Value and Forecast (2018-2029) & (USD Million)
Figure 12. Global Pandemic Influenza Vaccine Sales Quantity (2018-2029) & (M Units)
Figure 13. Global Pandemic Influenza Vaccine Average Price (2018-2029) & (US$/Unit)
Figure 14. Global Pandemic Influenza Vaccine Sales Quantity Market Share by Manufacturer in 2022
Figure 15. Global Pandemic Influenza Vaccine Consumption Value Market Share by Manufacturer in 2022
Figure 16. Producer Shipments of Pandemic Influenza Vaccine by Manufacturer Sales Quantity ($MM) and Market Share (%): 2021
Figure 17. Top 3 Pandemic Influenza Vaccine Manufacturer (Consumption Value) Market Share in 2022
Figure 18. Top 6 Pandemic Influenza Vaccine Manufacturer (Consumption Value) Market Share in 2022
Figure 19. Global Pandemic Influenza Vaccine Sales Quantity Market Share by Region (2018-2029)
Figure 20. Global Pandemic Influenza Vaccine Consumption Value Market Share by Region (2018-2029)
Figure 21. North America Pandemic Influenza Vaccine Consumption Value (2018-2029) & (USD Million)
Figure 22. Europe Pandemic Influenza Vaccine Consumption Value (2018-2029) & (USD Million)
Figure 23. Asia-Pacific Pandemic Influenza Vaccine Consumption Value (2018-2029) & (USD Million)
Figure 24. South America Pandemic Influenza Vaccine Consumption Value (2018-2029) & (USD Million)
Figure 25. Middle East & Africa Pandemic Influenza Vaccine Consumption Value (2018-2029) & (USD Million)
Figure 26. Global Pandemic Influenza Vaccine Sales Quantity Market Share by Type (2018-2029)
Figure 27. Global Pandemic Influenza Vaccine Consumption Value Market Share by Type (2018-2029)
Figure 28. Global Pandemic Influenza Vaccine Average Price by Type (2018-2029) & (US$/Unit)
Figure 29. Global Pandemic Influenza Vaccine Sales Quantity Market Share by Application (2018-2029)
Figure 30. Global Pandemic Influenza Vaccine Consumption Value Market Share by Application (2018-2029)
Figure 31. Global Pandemic Influenza Vaccine Average Price by Application (2018-2029) & (US$/Unit)
Figure 32. North America Pandemic Influenza Vaccine Sales Quantity Market Share by Type (2018-2029)
Figure 33. North America Pandemic Influenza Vaccine Sales Quantity Market Share by Application (2018-2029)
Figure 34. North America Pandemic Influenza Vaccine Sales Quantity Market Share by Country (2018-2029)
Figure 35. North America Pandemic Influenza Vaccine Consumption Value Market Share by Country (2018-2029)
Figure 36. United States Pandemic Influenza Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 37. Canada Pandemic Influenza Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 38. Mexico Pandemic Influenza Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 39. Europe Pandemic Influenza Vaccine Sales Quantity Market Share by Type (2018-2029)
Figure 40. Europe Pandemic Influenza Vaccine Sales Quantity Market Share by Application (2018-2029)
Figure 41. Europe Pandemic Influenza Vaccine Sales Quantity Market Share by Country (2018-2029)
Figure 42. Europe Pandemic Influenza Vaccine Consumption Value Market Share by Country (2018-2029)
Figure 43. Germany Pandemic Influenza Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 44. France Pandemic Influenza Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 45. United Kingdom Pandemic Influenza Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 46. Russia Pandemic Influenza Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 47. Italy Pandemic Influenza Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 48. Asia-Pacific Pandemic Influenza Vaccine Sales Quantity Market Share by Type (2018-2029)
Figure 49. Asia-Pacific Pandemic Influenza Vaccine Sales Quantity Market Share by Application (2018-2029)
Figure 50. Asia-Pacific Pandemic Influenza Vaccine Sales Quantity Market Share by Region (2018-2029)
Figure 51. Asia-Pacific Pandemic Influenza Vaccine Consumption Value Market Share by Region (2018-2029)
Figure 52. China Pandemic Influenza Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 53. Japan Pandemic Influenza Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 54. Korea Pandemic Influenza Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 55. India Pandemic Influenza Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 56. Southeast Asia Pandemic Influenza Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 57. Australia Pandemic Influenza Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 58. South America Pandemic Influenza Vaccine Sales Quantity Market Share by Type (2018-2029)
Figure 59. South America Pandemic Influenza Vaccine Sales Quantity Market Share by Application (2018-2029)
Figure 60. South America Pandemic Influenza Vaccine Sales Quantity Market Share by Country (2018-2029)
Figure 61. South America Pandemic Influenza Vaccine Consumption Value Market Share by Country (2018-2029)
Figure 62. Brazil Pandemic Influenza Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 63. Argentina Pandemic Influenza Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 64. Middle East & Africa Pandemic Influenza Vaccine Sales Quantity Market Share by Type (2018-2029)
Figure 65. Middle East & Africa Pandemic Influenza Vaccine Sales Quantity Market Share by Application (2018-2029)
Figure 66. Middle East & Africa Pandemic Influenza Vaccine Sales Quantity Market Share by Region (2018-2029)
Figure 67. Middle East & Africa Pandemic Influenza Vaccine Consumption Value Market Share by Region (2018-2029)
Figure 68. Turkey Pandemic Influenza Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 69. Egypt Pandemic Influenza Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 70. Saudi Arabia Pandemic Influenza Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 71. South Africa Pandemic Influenza Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 72. Pandemic Influenza Vaccine Market Drivers
Figure 73. Pandemic Influenza Vaccine Market Restraints
Figure 74. Pandemic Influenza Vaccine Market Trends
Figure 75. Porters Five Forces Analysis
Figure 76. Manufacturing Cost Structure Analysis of Pandemic Influenza Vaccine in 2022
Figure 77. Manufacturing Process Analysis of Pandemic Influenza Vaccine
Figure 78. Pandemic Influenza Vaccine Industrial Chain
Figure 79. Sales Quantity Channel: Direct to End-User vs Distributors
Figure 80. Direct Channel Pros & Cons
Figure 81. Indirect Channel Pros & Cons
Figure 82. Methodology
Figure 83. Research Process and Data Source
